Using ‘omics to unravel the pathophysiology and repurpose drugs to treat ME/CFS

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1199363

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The cause(s) of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not well known, but may involve altered function by the component of the cell that produces energy (mitochondria). We will use cutting edge stem cell technology to investigate this in detail and generate vital new knowledge that could identify new targets for the treatment of ME/CFS. We will also use a complex technology to screen a library of drugs to identify those that may be useful in the treatment of ME/CFS.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Targeted Calls for Research

Funding Amount: $1,083,010.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

drug discovery | gene expression | metabolomics | stem cell biology

Related Links